Atlas Trials

Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers

Clinical trial NCT05095389 · UNKNOWN

Trial details

NCT number
NCT05095389
Sponsor
Paracrine, INC.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Foot Ulcer
Start date
2023-02-28
Primary completion
2024-12-01
Enrollment
290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.